Clomiphene is an oral drug that has long been widely used in infertility treatment. Clomiphene has been used to help women conceive for decades. As a result, many doctors and patients are willing to use it as a first-line treatment.
Letrozole is an ovulation induction and super-ovulation medicine. Letrozole is an aromatase inhibitor, which was initially used to treat breast cancer. It works by persuading the pituitary (a tiny gland in the brain) to release FSH and LH (hormones) into the ovary, where they stimulate the formation of follicles (egg homes). The egg matures as the follicles enlarge, preparing to be released into the pelvis and hopefully fertilized by a sperm.
Letrozole appears to be more effective than Clomid at conceiving babies (especially for women with PCOS). Letrozole also offers fewer adverse effects and a lower risk of multiple pregnancies than Clomiphene.
Headache, muscle aches, nausea, and exhaustion are the most prevalent side effects. Twins and higher-order multiples appear to be less dangerous than Clomiphene.
Clomiphene belongs to the class of drugs known as selective oestrogen receptor modulators (SERM). Clomiphene's job is to persuade the brain that oestrogen levels are high enough to promote the production of hormones from the pituitary gland, a tiny gland in the brain. FSH and LH are hormones that travel to the ovary and induce follicle growth (the houses of the eggs). The egg matures and prepares to be released into the pelvis, where sperm will hopefully fertilize it as the follicles enlarge.
In circumstances where a woman does not ovulate (release an egg) monthly, ovulation induction is used. Super-ovulation is a technique used by women who frequently ovulate to enhance the number of eggs they can produce in a month and, as a result, their chances of conceiving. Clomiphene is commonly used in conjunction with other drugs.
Hot flashes, moodiness, and endometrial thinning are the most prevalent side effects of Clomiphene (Clomid) (the lining of the uterus). Visual changes are a rare adverse effect that should be mentioned to your doctor right away. With Clomiphene, the likelihood of having twins is about 8% (8/100), and the chance of having triplets is about 1/250.
Endocrinologists specializing in reproductive health, Dr Prachi, is an expert when it comes to infertility treatments.
Ovulation induction is a procedure that can be used for two purposes. The first is when a woman does not ovulate consistently. Some women may require medication to aid with ovulation (release eggs). As part of a treatment for unexplained infertility, drugs may be administered to assist her release more than one egg. The drugs cause the ovary to release eggs. The second situation is when a woman ovulates independently but can still conceive. If ovulation induction is correct for you, talk to your doctor.
Clomiphene citrate (CC), aromatase inhibitors (AIs) like letrozole and anastrozole, and insulin-sensitizing agents (ISAs) like metformin and thiazolidinedione are the most often utilized medications.
Estrogen (hormone) levels are low during the initial days of a typical menstrual cycle, and your pituitary gland responds by producing follicle-stimulating hormone (FSH). One primary follicle (a tiny cyst that holds an egg) grows and produces estrogen as FSH levels rise. This will cause that follicle to release an egg later in the cycle.
CC and AIs function by reducing estrogen levels or fooling the brain into believing they are low. CC works by assisting cells in their resistance to estrogen. AIs function by preventing androgens (male hormones) from converting to estrogen. Low estrogen levels cause the pituitary gland to create FSH, which aids the growth and release of an egg from a follicle.
Women with the polycystic ovarian syndrome (PCOS) create too much insulin and androgens because they don't ovulate regularly. ISAs enhance the growth of follicles by reducing insulin and androgen levels. ISAs can be employed independently or in conjunction with CC or AIs. They are sometimes used in those who have been diagnosed with pre-diabetes.
Multiple pregnancies are the most common danger. With CC and AIs, the chance of twins is 5 per cent -8 per cent, and the chance of triplets or higher-order multiple pregnancies is less than 1%. ISAs do not appear to significantly enhance the likelihood of multiple pregnancies, if at all. Ovarian cysts can form and sometimes grow large and painful; however, therapy for ovarian cysts is unusual.
No evidence taking these medications to promote ovulation increases the risk of birth abnormalities in women.
Based on your medical history and the cause of your infertility, your doctor will determine how much monitoring you require. Some women use home ovulation-predictor kits to determine when an egg will be released. This can aid in synchronizing intercourse with the fertile window (when the egg is released). Your doctor may also request that you come in for an ultrasound to determine when an egg will be discharged.
A variety of circumstances determines the success of these drugs. Nearly 80% of women who use CC or AIs for several months and are not currently ovulating will ovulate. Some women will require higher medication doses. These drugs are more successful in women who do not ovulate regularly. Pregnancy rates are lower in women who have previously ovulated, mainly if the medicines aren't used with other treatments like insemination. The likelihood of being pregnant is determined by your age, the length of your infertility, and the cause of your infertility. Your doctor will provide you with specific information regarding your possibilities of becoming pregnant
For unplanned pregnancy plans Contact Us